Pharmacokinetic and pharmacodynamic properties of SOL1: A novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme

J. Nelissen, P. Lemkens, H. Sann, M. Bindl, F. Bassissi, D. Jasserand, J. G. R. De Mey, B. J. A. Janssen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)
Original languageEnglish
Pages (from-to)587-592
JournalLife Sciences
Issue number13-14
Publication statusPublished - 15 Oct 2012


  • Endothelin converting enzyme
  • Neutral endopeptidase
  • Calcitonin gene-related peptide
  • Metalloproteases
  • Kidney

Cite this